Cognitive therapy for schizophrenia: A preliminary randomized controlled trial

Schizophrenia Research

Volumn 63, Issue 1-2, 2003, Pages 1-11

  Rector, Neil A ^a   Seeman, Mary V ^a   Segal, Zindel V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Schizophrenia; Therapy; Treatment

Indexed keywords

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICAL ASSESSMENT; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 0042709230     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(02)00308-0     Document Type: Article

References (35)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th edn. 1994;American Psychiatric Association, Washington, DC.
2. Beck A.T., Rector N.A. Cognitive therapy of schizophrenia: a new therapy for the new millennium. Am. J. Psychotherapy. 54:2000;291-300.
3. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry. 4:1961;561-571.
4. Beck A.T., Rush A.J., Shaw B.F., Emery G. Cognitive Therapy of Depression. 1979;Guilford Press, New York.
5. Beck A.T., Emery G., Greenberg R.L. Anxiety Disorders and Phobias: A Cognitive Perspective. 1985;Basic Books, New York.
6. Bezchlibnyk-Butler K.Z., Jeffries J.J. Clinical Handbook of Psychotropic Drugs. 11th edn. 2001;Hogrefe & Huber, Toronto.
7. Carpenter W.T.J., Conley R.R., Buchanan R.W., Breier A., Taminga C.A. Patient response and resource management: another view of clozapine treatment of schizophrenia. Am. J. Psychiatry. 152:1995;827-832.
8. Chadwick P.D., Birchwood M.J. Challenging the omnipotence of voices: a cognitive approach to auditory hallucinations. Br. J. Psychiatry. 164:1994;190-201.
9. Chadwick P.D.J., Birchwood M., Trower P. Cognitive therapy for delusions, voices, and paranoia. 1996;Wiley, New York.
10. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edn. 1988;Lawrence Erlbaum, New Jersey.
11. Drury V., Birchwood M., Cochrane R., MacMillan F. Cognitive therapy and recovery from acute psychosis: a controlled trial: I. Impact on psychotic symptoms. Br. J. Psychiatry. 169:1996a;593-601.
12. Drury V., Birchwood M., Cochrane R., MacMillan F. Cognitive therapy and recovery from acute psychosis: a controlled trial: II. Impact on recovery time. Br. J. Psychiatry. 169:1996b;602-607.
13. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P, version 2). Biometrics Research. 1995;New York State Psychiatric Institute, New York.
14. Fowler D., Garety P., Kuipers E. Cognitive Behaviour Therapy for Psychosis: Theory and Practice. 1995;Wiley, New York.
15. Garety P., Fowler D., Kuipers E., Freeman D., Dunn G., Bebbington P., Hadley C., Jones S. London-East Anglia randomized controlled trial of cognitive-behavioral therapy for psychosis: II. Predictors of outcome. Br. J. Psychiatry. 171:1997;420-426.
16. Kay S., Fiszbein A., Opler L. The Positive and Negative Syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13:1987;261-276.
17. Kingdon D., Turkington D. Cognitive Behavioral Therapy of Schizophrenia. 1994;Guilford, New York.
18. Kuipers E., Garety P., Fowler D., Dunn G., Bebbington P., Freeman D., Hadley C. London-East Anglia randomized controlled trial of cognitive-behavioral therapy for psychosis: I. Effects of the treatment phase. Br. J. Psychiatry. 171:1997;319-327.
19. Lapierre Y.D., Angus C., Awad A.G., Saxena B.M., Jones B.et al. The treatment of negative symptoms: a clinical and methodological study. Int. Clin. Psychopharmacol. 14:1999;101-112.
20. Lewine R.R.J. A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication. Am. J. Psychiatry. 147:1990;14.
21. McGlashan T.H., Fenton W.S. Subtype progression and pathophysiologic deterioration in early schizophrenia. Schizophr. Bull. 19:1993;71-84.
22. Meltzer H.Y., Casey D.E., Garver D.L., Marder S.R., Masand P.S., Miller D.et al. Assessing the effects of atypical antipsychotics on negative symptoms. J. Clin. Psychiatry. 59:1998;28-34.
23. Nelson H.E. The National Adult Reading Test. 1982;NFER-Nelson, Windsor, Berks.
24. Nunnally J.C., Bernstein I.H. Psychometric Theory. 3rd edn. 1994;McGraw-Hill, New York.
25. Pinto A., La Pia S., Mannella R., Domenico G., DeSimone L. Cognitive-behavioral therapy and clozapine for clients with treatment-refractory schizophrenia. Psychiatr. Serv. 50:1999;901-904.
26. Rector N.A., Beck A.T. Cognitive behavioural therapy of schizophrenia: an empirical review. J. Nerv. Ment. Dis. 189:2001;278-287.
27. Rector N.A., Beck A.T. Cognitive therapy for schizophrenia: from conceptualisation to intervention. Can. J. Psychiatry. 47:2002;39-48.
28. Sensky T., Turkington D., Kingdon D., Scott J.L., Scott J., Siddle R., O'Carroll M. Barnes TRE: a randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Arch. Gen. Psychiatry. 57:2000;165-172.
29. Siris S.G., Adan F., Cohen M., Mandeli J., Aronson A., Casey E. Post-psychotic depression and negative symptoms: an investigation of syndromal overlap. Am. J. Psychiatry. 145:1988;1532-1537.
30. Stahl S.M. Selecting atypical antipsychotic by combining clinical experience with guidelines from clinical trials. J. Clin. Psychiatry. 60:1999;31-41.
31. Tarrier N. Psychological treatment of schizophrenic symptoms. Kavanagh D. Schizophrenia: An Overview and Practical Handbook. 1992;Chapman & Hall, London.
32. Tarrier N., Beckett R., Harwood S., Baker A., Yusupoff L., Ugarteburu I. A trial of two cognitive-behavioral methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome. Br. J. Psychiatry. 162:1993;524-532.
33. Tarrier N., Yusupoff L., Kinney C., McCarthy E., Gledhill A., Haddock G., Morris J. Randomized controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. Br. Med. J. 317:1998;303-307.
34. Tarrier N., Wittkowski A., Kinney C., McCarthy E., Morris J., Humphreys L. Durability of the effects of cognitive-behavioral therapy in the treatment of chronic schizophrenia: 12-month follow-up. Br. J. Psychiatry. 174:1999;500-504.
35. Tollefson G.D., Sanger T.M. Negative symptoms: a path analytic approach to a double blind placebo and haloperidol controlled clinical trial with olanzepine. Am. J. Psychiatry. 154:1997;446-474.